Cargando…

Taking the route less traveled: on the way to COpAT

Antimicrobial therapy is an essential practice within medicine. Over the last 4 years, complex outpatient antimicrobial therapy (COpAT) with oral antimicrobials has become a rapidly developing area of practice and is non-inferior to outpatient parenteral antimicrobial therapy (OPAT) in certain infec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pertzborn, Margaret, Rivera, Christina G., Tai, Don Bambino Geno
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2023
Materias:	Outpatient Parenteral Antimicrobial Therapy
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10433885/ https://www.ncbi.nlm.nih.gov/pubmed/37600977 http://dx.doi.org/10.1177/20499361231192771

Ejemplares similares

Pushing the agenda for intravenous push administration in outpatient parenteral antimicrobial therapy
por: Johnson, Tanner M., et al.
Publicado: (2023)

A review of evidence, antimicrobial stability, and feasibility considerations for OPAT continuous infusion
por: Van Abel, Amy L., et al.
Publicado: (2023)

Comparative renal risk of long-term use of beta-lactams in combination with vancomycin across the continuum of care
por: Dolly, Lauren M., et al.
Publicado: (2023)

Outpatient parenteral antimicrobial therapy in Brazil
por: Oliveira, Priscila R, et al.
Publicado: (2023)

Predictors of adverse safety events and unscheduled care among an outpatient parenteral antimicrobial therapy (OPAT) patient cohort
por: Billmeyer, Kaylyn N., et al.
Publicado: (2023)

From sea to shining IV: the current state of OPAT in the United States
por: Larnard, Jeffrey, et al.
Publicado: (2023)

What is the role of the clinical microbiology laboratory in the care of diagnostically challenging OPAT patients? Illustrative cases and literature review
por: Nori, Priya, et al.
Publicado: (2023)

Identifying the potential impact of a multidisciplinary outpatient antimicrobial therapy program in an area of high social vulnerability
por: Tan, Karen K., et al.
Publicado: (2023)

Facilitating OPAT in rural areas
por: Mehta, Meera, et al.
Publicado: (2023)

Exploring the advancements of Australian OPAT
por: Lai, Tony, et al.
Publicado: (2023)

Retrospective analysis of the management of pelvic decubitus ulcers and their outcomes
por: Damioli, Laura, et al.
Publicado: (2023)

An evaluation of risk factors for readmission in patients receiving outpatient parenteral antimicrobial therapy
por: Bradley, Abby C., et al.
Publicado: (2023)

The hidden cost of dalbavancin: OPAT RN time required in coordination for persons who use drugs
por: Douglass, Alyse H., et al.
Publicado: (2023)

619. Current State of Infectious Diseases Pharmacist OPAT/COpAT Practice in the United States
por: Rivera, Christina G, et al.
Publicado: (2021)

598. Choosing Wisely with CD4 Counts: When Less Is More
por: Tai, Don Bambino Geno, et al.
Publicado: (2018)

Benefits of quitting smoking on work productivity and activity impairment in the United States, the European Union and China
por: Baker, Christine L., et al.
Publicado: (2017)

Cutaneous leishmaniasis in a returned traveler
por: Kundu, Rupayan, et al.
Publicado: (2022)

Exploring patient acceptance of research within complex oral and IV outpatient parenteral antimicrobial therapy (COpAT) networks
por: Rawson, Timothy M, et al.
Publicado: (2022)

357. High Rate of Adverse Events in Patients Receiving Oral Antimicrobials Under a COpAT Monitoring Protocol
por: Sawey, Ciara, et al.
Publicado: (2023)

General Principles of Antimicrobial Therapy
por: Leekha, Surbhi, et al.
Publicado: (2011)

Antiviral Drugs for Viruses Other Than Human Immunodeficiency Virus
por: Razonable, Raymund R.
Publicado: (2011)

Omadacycline Enters the Ring: A New Antimicrobial Contender
por: Barber, Katie E., et al.
Publicado: (2018)

333. How the COVID-19 Pandemic Accelerated Development of our Complex Outpatient Oral Antimicrobial Therapy (COpAT) Program
por: Juskowich, Joy J, et al.
Publicado: (2023)

Increasingly limited options for the treatment of enteric fever in travellers returning to England, 2014–2019: a cross-sectional analytical study
por: Herdman, M. Trent, et al.
Publicado: (2021)

2194. Procalcitonin-Guided Antibiotic Strategy for Lower Respiratory Tract Infections: Outcomes and Safety of Withholding Antibiotics
por: Bambino Geno Tai, Don, et al.
Publicado: (2019)

Outcomes of COVID-19 With the Mayo Clinic Model of Care and Research
por: Tai, Don Bambino Geno, et al.
Publicado: (2021)

Nutrición enteral y parenteral
Publicado: (1993)

Endonutrición : estado del arte en nutrición clínica /
Publicado: (2007)

Endonutrición : apoyo nutricio /
Publicado: (2013)

CpxR promotes the carbapenem antibiotic resistance of Klebsiella pneumoniae by directly regulating the expression and the dissemination of bla(KPC) on the IncFII conjugative plasmid
por: Liu, Zhiyuan, et al.
Publicado: (2023)

Functional diversity increases the efficacy of phage combinations
por: Wright, Rosanna C. T., et al.
Publicado: (2021)

A Novel Cecropin D-Derived Short Cationic Antimicrobial Peptide Exhibits Antibacterial Activity Against Wild-Type and Multidrug-Resistant Strains of Klebsiella pneumoniae and Pseudomonas aeruginosa
por: Ocampo-Ibáñez, Iván Darío, et al.
Publicado: (2020)

The Safety and Efficacy of Dalbavancin and Active Comparator in Pediatric Patients With Acute Bacterial Skin and Skin Structure Infections
por: Giorgobiani, Manana, et al.
Publicado: (2022)

Genital nodular scabies
por: Tai, Don Bambino Geno, et al.
Publicado: (2020)

Safety, Efficacy and Pharmacokinetics of Anidulafungin in Patients 1 Month to <2 Years of Age With Invasive Candidiasis, Including Candidemia
por: Roilides, Emmanuel, et al.
Publicado: (2020)

SaeR as a novel target for antivirulence therapy against Staphylococcus aureus
por: Gao, Peng, et al.
Publicado: (2023)

Peripheral Regulatory T Cells Take the Road Less Traveled
por: Heller, Kira
Publicado: (2009)

Pancreas as an Occult Source of Recurrent Salmonella enteritidis Bacteremia in an Immunocompromised Patient
por: Tai, Don Bambino Geno, et al.
Publicado: (2018)

Activity of Plazomicin (ACHN-490) against MDR clinical isolates of Klebsiella pneumoniae, Escherichia coli, and Enterobacter spp. from Athens, Greece
por: Galani, Irene, et al.
Publicado: (2012)

Micafungin in Premature and Non-premature Infants: A Systematic Review of 9 Clinical Trials
por: Manzoni, Paolo, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_2rofutoi093lkp7jn8eqp8hd6b